Elastic N.V.

ESTC

CIK 0001707753 · Quarterly mode · latest period FY2026 (Q4) (ending 2026-01-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q4)

Revenue
$450M
↑+17.7% +$68Mvs FY2025 (Q4)
Operating Income
$611K
↓-99.7% -$175Mvs FY2025 (Q4)
Gross Profit
$343M
↑+20.5% +$59Mvs FY2025 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
57/100
  • Profitability
    0ROIC -3.1% (10% = solid, 20%+ = moat)
  • Liquidity
    71Current Ratio 1.92 (above 1.5 = solid)
  • Leverage
    69D/E 0.61 (under 0.5 = conservative)
  • Efficiency
    32Asset Turnover 0.61x (1.0+ = capital-efficient)
  • Growth
    76Revenue YoY +17.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    95Op Margin 0.1% · trend +2.7pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ESTC's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 334.7%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$84.24
Total enterprise IV
$8.73B
Diluted shares
0.10B
Terminal PV
$6.78B (78% of total)
Year-5 FCF
$799M
YearProjected FCFDiscounted PV
+1$327M$298M
+2$409M$338M
+3$511M$384M
+4$639M$437M
+5$799M$496M
Terminal$10.92B$6.78B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$4M
investment in PP&E
Stock buybacks (TTM)
$300M
share count reduction
Stock-based comp (TTM)
non-cash dilution

Balance sheet · 2026-01-31

latest filed snapshot
Total assets
$2.44B
everything owned
Total liabilities
$1.65B
everything owed
Stockholders' equity
$791M
shareholder claim
Net debt
$-167M
Net cash position ($167M)

Recent performance · 35 quarters

Revenue↑+17.7% +$68M
$450M
Net Income↑+145.5% +$25M
$8M
Free Cash Flow↓-52.1% -$45M
$42M
Operating Margin↑+1.3pts
0.1%

Drill down